(Q35094691)

6 August 2017

1 reference

title

Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic (English)

1 reference

6 August 2017

2

Susan L McElroy

1 reference

6 August 2017

1

Paul E Keck

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Expert Opinion on Investigational Drugs

6 August 2017

published in

1 reference

6 August 2017

volume

12

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

655-662

1 reference

Dopamine in schizophrenia: a review and reconceptualization

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Schizophrenia: diverse approaches to a complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

The new generation of antipsychotic drugs: how atypical are they?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Pharmacologic agents for the treatment of acute bipolar mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Schizophrenia: the characteristic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

Ziprasidone: a new atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.655

10.1517/13543784.12.4.655

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference